https://www.selleckchem.com/pr....oducts/ldc195943-imt
sporin, azithromycin and either low-dose lopinavir/ritonavir or hydroxychloroquine was not associated with better clinical outcomes in terms of time to symptom resolution, time to viral clearance, and hospital stay duration compared to standard supportive treatment alone. Microbiological evidence should be closely monitored when treating SARS-CoV-2 patients with antibiotics to prevent indiscreet administration of empirical antimicrobial treatments. Combined treatment of 3rd cephalosporin, azithromycin and either low-dose lopinavi
Like
Comment
Share
